189 related articles for article (PubMed ID: 6460554)
1. Isolation of fluoropyrimidine-resistant murine leukemic cell lines by one-step mutation and selection.
Mulkins MA; Heidelberger C
Cancer Res; 1982 Mar; 42(3):956-64. PubMed ID: 6460554
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of fluoropyrimidine-resistant murine leukemic cell lines.
Mulkins MA; Heidelberger C
Cancer Res; 1982 Mar; 42(3):965-73. PubMed ID: 7059992
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil.
Ardalan B; Cooney DA; Jayaram HN; Carrico CK; Glazer RI; Macdonald J; Schein PS
Cancer Res; 1980 May; 40(5):1431-7. PubMed ID: 6245793
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
[TBL] [Abstract][Full Text] [Related]
5. Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines.
Cao D; Russell RL; Zhang D; Leffert JJ; Pizzorno G
Cancer Res; 2002 Apr; 62(8):2313-7. PubMed ID: 11956089
[TBL] [Abstract][Full Text] [Related]
6. Effect of uridine on response of 5-azacytidine-resistant human leukemic cells to inhibitors of de novo pyrimidine synthesis.
Grant S; Bhalla K; Gleyzer M
Cancer Res; 1984 Dec; 44(12 Pt 1):5505-10. PubMed ID: 6208998
[TBL] [Abstract][Full Text] [Related]
7. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
Kim K; Blechman WJ; Riddle VG; Pardee AB
Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
[TBL] [Abstract][Full Text] [Related]
8. Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells.
Keyomarsi K; Moran RG
Cancer Res; 1986 Oct; 46(10):5229-35. PubMed ID: 2944577
[TBL] [Abstract][Full Text] [Related]
9. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells.
Cai J; Damaraju VL; Groulx N; Mowles D; Peng Y; Robins MJ; Cass CE; Gros P
Cancer Res; 2008 Apr; 68(7):2349-57. PubMed ID: 18381442
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of the murine lymphoma L5178Y cell line highly resistant to 5-fluorouracil.
Kanzawa F; Hoshi A; Kuretani K
J Pharmacobiodyn; 1980 Aug; 3(8):390-4. PubMed ID: 6451684
[TBL] [Abstract][Full Text] [Related]
11. Establishment of cross-resistance profiles for new agents.
Schabel FM; Skipper HE; Trader MW; Laster WR; Griswold DP; Corbett TH
Cancer Treat Rep; 1983 Oct; 67(10):905-22. PubMed ID: 6354439
[TBL] [Abstract][Full Text] [Related]
12. Defective facilitated diffusion of nucleosides, a primary mechanism of resistance to 5-fluoro-2'-deoxyuridine in the HCT-8 human carcinoma line.
Sobrero AF; Moir RD; Bertino JR; Handschumacher RE
Cancer Res; 1985 Jul; 45(7):3155-60. PubMed ID: 3159474
[TBL] [Abstract][Full Text] [Related]
13. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
Grant S; Cadman E
Cancer Res; 1982 Sep; 42(9):3550-6. PubMed ID: 6213294
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J
Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of alkylesters of 1-beta-D-ribofuranosyl-5-fluorouracil-5'-phosphate against murine lymphoma L5178Y resistant to 1-beta-D-ribofuranosyl-5-fluorouracil.
Kanzawa F; Hoshi A; Kuretani K
Bull Cancer; 1979; 66(5):497-501. PubMed ID: 554675
[TBL] [Abstract][Full Text] [Related]
16. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
[TBL] [Abstract][Full Text] [Related]
17. Characterization of four drug-resistant P388 sublines: resistance/sensitivity in vivo, resistance-and proliferation-markers, immunogenicity.
Fichtner I; Stein U; Hoffmann J; Winterfeld G; Pfeil D; Hentschel M
Anticancer Res; 1994; 14(5A):1995-2003. PubMed ID: 7847840
[TBL] [Abstract][Full Text] [Related]
18. Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines.
Sladek NE; Landkamer GJ
Cancer Res; 1985 Apr; 45(4):1549-55. PubMed ID: 3978623
[TBL] [Abstract][Full Text] [Related]
19. High calcium content of pleiotropic drug-resistant P388 and K562 leukemia and Chinese hamster ovary cells.
Tsuruo T; Iida H; Kawabata H; Tsukagoshi S; Sakurai Y
Cancer Res; 1984 Nov; 44(11):5095-9. PubMed ID: 6593116
[TBL] [Abstract][Full Text] [Related]
20. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo.
Sirotnak FM; Moccio DM; Kelleher LE; Goutas LJ
Cancer Res; 1981 Nov; 41(11 Pt 1):4447-52. PubMed ID: 7306968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]